224 related articles for article (PubMed ID: 9931334)
1. Increased expression of the NF2 tumor suppressor gene product, merlin, impairs cell motility, adhesionand spreading.
Gutmann DH; Sherman L; Seftor L; Haipek C; Hoang Lu K; Hendrix M
Hum Mol Genet; 1999 Feb; 8(2):267-75. PubMed ID: 9931334
[TBL] [Abstract][Full Text] [Related]
2. Interaction between two isoforms of the NF2 tumor suppressor protein, merlin, and between merlin and ezrin, suggests modulation of ERM proteins by merlin.
Meng JJ; Lowrie DJ; Sun H; Dorsey E; Pelton PD; Bashour AM; Groden J; Ratner N; Ip W
J Neurosci Res; 2000 Nov; 62(4):491-502. PubMed ID: 11070492
[TBL] [Abstract][Full Text] [Related]
3. The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44.
Morrison H; Sherman LS; Legg J; Banine F; Isacke C; Haipek CA; Gutmann DH; Ponta H; Herrlich P
Genes Dev; 2001 Apr; 15(8):968-80. PubMed ID: 11316791
[TBL] [Abstract][Full Text] [Related]
4. Effect of merlin phosphorylation on neurofibromatosis 2 (NF2) gene function.
Surace EI; Haipek CA; Gutmann DH
Oncogene; 2004 Jan; 23(2):580-7. PubMed ID: 14724586
[TBL] [Abstract][Full Text] [Related]
5. Universal absence of merlin, but not other ERM family members, in schwannomas.
Stemmer-Rachamimov AO; Xu L; Gonzalez-Agosti C; Burwick JA; Pinney D; Beauchamp R; Jacoby LB; Gusella JF; Ramesh V; Louis DN
Am J Pathol; 1997 Dec; 151(6):1649-54. PubMed ID: 9403715
[TBL] [Abstract][Full Text] [Related]
6. Functional analysis of the neurofibromatosis type 2 protein by means of disease-causing point mutations.
Stokowski RP; Cox DR
Am J Hum Genet; 2000 Mar; 66(3):873-91. PubMed ID: 10712203
[TBL] [Abstract][Full Text] [Related]
7. The protein 4.1 tumor suppressor, DAL-1, impairs cell motility, but regulates proliferation in a cell-type-specific fashion.
Gutmann DH; Hirbe AC; Huang ZY; Haipek CA
Neurobiol Dis; 2001 Apr; 8(2):266-78. PubMed ID: 11300722
[TBL] [Abstract][Full Text] [Related]
8. Evolution and origin of merlin, the product of the Neurofibromatosis type 2 (NF2) tumor-suppressor gene.
Golovnina K; Blinov A; Akhmametyeva EM; Omelyanchuk LV; Chang LS
BMC Evol Biol; 2005 Dec; 5():69. PubMed ID: 16324214
[TBL] [Abstract][Full Text] [Related]
9. Homotypic and heterotypic interaction of the neurofibromatosis 2 tumor suppressor protein merlin and the ERM protein ezrin.
Grönholm M; Sainio M; Zhao F; Heiska L; Vaheri A; Carpén O
J Cell Sci; 1999 Mar; 112 ( Pt 6)():895-904. PubMed ID: 10036239
[TBL] [Abstract][Full Text] [Related]
10. ERM proteins and NF2 tumor suppressor: the Yin and Yang of cortical actin organization and cell growth signaling.
Gautreau A; Louvard D; Arpin M
Curr Opin Cell Biol; 2002 Feb; 14(1):104-9. PubMed ID: 11792551
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the neurofibromatosis type 2 tumor suppressor protein, merlin, by adhesion and growth arrest stimuli.
Shaw RJ; McClatchey AI; Jacks T
J Biol Chem; 1998 Mar; 273(13):7757-64. PubMed ID: 9516485
[TBL] [Abstract][Full Text] [Related]
12. [Neurofibromatosis type 2 (NF2)].
Araki N; Takeshima H; Saya H
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136
[TBL] [Abstract][Full Text] [Related]
13. NF2: the wizardry of merlin.
Xiao GH; Chernoff J; Testa JR
Genes Chromosomes Cancer; 2003 Dec; 38(4):389-99. PubMed ID: 14566860
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase A-mediated phosphorylation of the NF2 tumor suppressor protein merlin at serine 10 affects the actin cytoskeleton.
Laulajainen M; Muranen T; Carpén O; Grönholm M
Oncogene; 2008 May; 27(23):3233-43. PubMed ID: 18071304
[TBL] [Abstract][Full Text] [Related]
15. Localization and functional domains of the neurofibromatosis type II tumor suppressor, merlin.
Shaw RJ; McClatchey AI; Jacks T
Cell Growth Differ; 1998 Apr; 9(4):287-96. PubMed ID: 9563848
[TBL] [Abstract][Full Text] [Related]
16. The neurofibromatosis type 2 gene product, merlin, reverses the F-actin cytoskeletal defects in primary human Schwannoma cells.
Bashour AM; Meng JJ; Ip W; MacCollin M; Ratner N
Mol Cell Biol; 2002 Feb; 22(4):1150-7. PubMed ID: 11809806
[TBL] [Abstract][Full Text] [Related]
17. Point mutation in the NF2 gene of HEI-193 human schwannoma cells results in the expression of a merlin isoform with attenuated growth suppressive activity.
Lepont P; Stickney JT; Foster LA; Meng JJ; Hennigan RF; Ip W
Mutat Res; 2008 Jan; 637(1-2):142-51. PubMed ID: 17868749
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the NF2 protein merlin and the ERM protein ezrin in human, rat, and mouse central nervous system.
Grönholm M; Teesalu T; Tyynelä J; Piltti K; Böhling T; Wartiovaara K; Vaheri A; Carpén O
Mol Cell Neurosci; 2005 Apr; 28(4):683-93. PubMed ID: 15797715
[TBL] [Abstract][Full Text] [Related]
19. Expression of NF2-encoded merlin and related ERM family proteins in the human central nervous system.
Stemmer-Rachamimov AO; Gonzalez-Agosti C; Xu L; Burwick JA; Beauchamp R; Pinney D; Louis DN; Ramesh V
J Neuropathol Exp Neurol; 1997 Jun; 56(6):735-42. PubMed ID: 9184664
[TBL] [Abstract][Full Text] [Related]
20. Expression level, subcellular distribution and rho-GDI binding affinity of merlin in comparison with Ezrin/Radixin/Moesin proteins.
Maeda M; Matsui T; Imamura M; Tsukita S; Tsukita S
Oncogene; 1999 Aug; 18(34):4788-97. PubMed ID: 10490812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]